Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
Authors
Keywords
-
Journal
Expert Review of Respiratory Medicine
Volume 10, Issue 6, Pages 699-711
Publisher
Informa UK Limited
Online
2016-04-20
DOI
10.1080/17476348.2016.1177461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nintedanib and Pirfenidone. New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Relationship between gene expression and lung function in Idiopathic Interstitial Pneumonias
- (2015) Mark P. Steele et al. BMC GENOMICS
- Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis
- (2015) Pierre-Simon Bellaye et al. BMC Medicine
- Effect of Pirfenidone on IPF-Related Mortality Outcome Measures in Patients With Idiopathic Pulmonary Fibrosis (IPF): Pooled Data Analysis From the ASCEND and CAPACITY Trials
- (2015) Steven Nathan et al. CHEST
- Pirfenidone and N-acetylcysteine (NAC) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF): Exploratory Efficacy Results From the PANORAMA Study
- (2015) Juergen Behr et al. CHEST
- Development of Novel Agents for Idiopathic Pulmonary Fibrosis
- (2015) Thomas G. O'Riordan et al. CHEST
- Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis
- (2015) David J. Lederer et al. CHEST
- Personalized medicine in idiopathic pulmonary fibrosis
- (2015) Paolo Spagnolo et al. CURRENT OPINION IN PULMONARY MEDICINE
- CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
- (2015) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
- (2015) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
- (2015) Yohannes T Ghebremariam et al. Journal of Translational Medicine
- Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening
- (2015) Bridget D Stuart et al. NATURE GENETICS
- Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
- (2015) Banu A. Karimi-Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction: Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
- (2015) Carlos Aravena et al. PLoS One
- Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study
- (2015) Susumu Sakamoto et al. RESPIROLOGY
- A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
- (2015) Yong Huang et al. BMC Pulmonary Medicine
- MicroRNAs as potential targets for progressive pulmonary fibrosis
- (2015) Subbiah Rajasekaran et al. Frontiers in Pharmacology
- Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data
- (2015) Su Yeon Kim et al. Lancet Respiratory Medicine
- Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2
- (2015) Amali P. Epa et al. PLoS One
- A Mathematical Model of Idiopathic Pulmonary Fibrosis
- (2015) Wenrui Hao et al. PLoS One
- Molecular biomarkers in idiopathic pulmonary fibrosis
- (2014) Brett Ley et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- New Therapeutic Targets in Idiopathic Pulmonary Fibrosis. Aiming to Rein in Runaway Wound-Healing Responses
- (2014) Neil Ahluwalia et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
- (2014) Takashi Ogura et al. EUROPEAN RESPIRATORY JOURNAL
- TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice
- (2014) Shaik O. Rahaman et al. JOURNAL OF CLINICAL INVESTIGATION
- PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
- (2014) Marta Bueno et al. JOURNAL OF CLINICAL INVESTIGATION
- Idiopathic Pulmonary Fibrosis: Evolving Concepts
- (2014) Jay H. Ryu et al. MAYO CLINIC PROCEEDINGS
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases
- (2014) Gian Luca Casoni et al. PLoS One
- Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
- (2014) L. Hecker et al. Science Translational Medicine
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
- (2014) MeiLan K Han et al. Lancet Respiratory Medicine
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
- (2013) William D. Travis et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
- (2013) Timothy S. Blackwell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules
- (2013) Keith C. Olsen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
- (2013) Brett Ley et al. ANNALS OF INTERNAL MEDICINE
- Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan
- (2013) Ganesh Raghu ANNALS OF INTERNAL MEDICINE
- Blood Biomarkers MMP-7 and SP-A
- (2013) Jin Woo Song et al. CHEST
- Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression
- (2013) J. W. Chien et al. EUROPEAN RESPIRATORY JOURNAL
- Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients
- (2013) Edoardo Savarino et al. EUROPEAN RESPIRATORY JOURNAL
- Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
- (2013) Anna L. Peljto et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
- (2013) Yong Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Idiopathic Pulmonary Fibrosis and Gastroesophageal Reflux. Implications for Treatment
- (2013) Marco E. Allaix et al. JOURNAL OF GASTROINTESTINAL SURGERY
- MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities
- (2013) Gary M. Hunninghake et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhalable Powder Formulation of Pirfenidone with Reduced Phototoxic Risk for Treatment of Pulmonary Fibrosis
- (2013) Satomi Onoue et al. PHARMACEUTICAL RESEARCH
- The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
- (2013) Raphael Borie et al. PLoS One
- Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
- (2013) M.R. Dillingh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms
- (2013) Khondoker M Akram et al. RESPIRATORY RESEARCH
- Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
- (2013) J. D. Herazo-Maya et al. Science Translational Medicine
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
- (2013) Joyce S Lee et al. Lancet Respiratory Medicine
- The Hedgehog System Machinery Controls Transforming Growth Factor-β–Dependent Myofibroblastic Differentiation in Humans
- (2012) Natacha Cigna et al. AMERICAN JOURNAL OF PATHOLOGY
- Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
- (2012) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
- (2012) Imre Noth et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Transforming Growth Factor–β Evokes Ca2+Waves and Enhances Gene Expression in Human Pulmonary Fibroblasts
- (2012) Subhendu Mukherjee et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Matrices of Physiologic Stiffness Potently Inactivate Idiopathic Pulmonary Fibrosis Fibroblasts
- (2012) Aleksandar Marinković et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The mechanical memory of lung myofibroblasts
- (2012) Jenna L. Balestrini et al. Integrative Biology
- United we stand – integrating the actin cytoskeleton and cell–matrix adhesions in cellular mechanotransduction
- (2012) Ulrich S. Schwarz et al. JOURNAL OF CELL SCIENCE
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Toward a systems level view of the ECM and related proteins: A framework for the systematic definition and analysis of biological systems
- (2012) Graham L. Cromar et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
- (2012) Ludmila Shulgina et al. THORAX
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Lysophosphatidic Acid Receptor LPA1Promotes Epithelial Cell Apoptosis after Lung Injury
- (2011) Manuela Funke et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- A Variant in the Promoter ofMUC5Band Idiopathic Pulmonary Fibrosis
- (2011) Yingze Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis
- (2011) Max A. Seibold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
- (2010) S. L. Schmidt et al. EUROPEAN RESPIRATORY JOURNAL
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis
- (2010) Syed R. Gilani et al. PLoS One
- Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
- (2010) Steven D. Knight et al. ACS Medicinal Chemistry Letters
- Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
- (2009) Thomas H. Sisson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Endothelin-1 and Transforming Growth Factor-β1 Independently Induce Fibroblast Resistance to Apoptosis via AKT Activation
- (2009) Priya Kulasekaran et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Phosphatidylinositol-3-Kinase/Akt Regulates Bleomycin-Induced Fibroblast Proliferation and Collagen Production
- (2009) Yongju Lu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen
- (2009) Markella Ponticos et al. ARTHRITIS AND RHEUMATISM
- Back to basics - how the evolution of the extracellular matrix underpinned vertebrate evolution
- (2009) Julie Huxley-Jones et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Assessment of Prognosis of Patients With Idiopathic Pulmonary Fibrosis by Computer-aided Analysis of CT Images
- (2009) Tae Iwasawa et al. JOURNAL OF THORACIC IMAGING
- The Extracellular Matrix: Not Just Pretty Fibrils
- (2009) R. O. Hynes SCIENCE
- Mechanically Activated Integrin Switch Controls 5 1 Function
- (2009) J. C. Friedland et al. SCIENCE
- Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis
- (2008) Martina Korfei et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2
- (2008) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Idiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs?
- (2008) Moisés Selman et al. PLOS MEDICINE
- MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
- (2008) Ivan O Rosas et al. PLOS MEDICINE
- Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis
- (2007) Khalid Puthawala et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now